Clinical Trial Update: Ranibizumab for Diabetic Traction Retinal Detachment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ranibizumab for diabetic traction retinal detachment has completed, reporting results for this indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Tractional Retinal Detachment

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetic Retinopathy, Retinal Detachment | Phase 2 | Status: COMPLETED